15th Annual International Ultmann Chicago Lymphoma Symposium
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of national practicing oncologists, advanced nurse practitioners and physician assistants, nurses, residents, fellows, and the Chicago academic community that includes five academic centers. This year’s program offered in May 2018 represents the 15th IUCLS.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster and abstract presentations, and an opportunity for question-and-answer debates. IUCLS is a two-day meeting held Friday and Saturday at the Kimpton Gray Hotel. Friday afternoon academic sessions concentrate on the scientific and translational aspects of lymphoma, while Saturday has a clinical focus. Additionally, the entire conference will be certified for nursing continuing education credits for the first time. A Friday morning session will be held that will specifically address the educational needs of nurses.
Learn more at the symposium website!
Learning Objectives and Target Audience
At the conclusion of this activity, participants will be able to:
- Describe the evolving role of cellular therapy in lymphoma treatment;
- Identify new targets and therapeutic agents in lymphoma treatment;
- Recognize the appropriate circumstances in which to use different immune-oncology options for lymphoma treatment;
- Evaluate how new scientific data affects the treatment of Hodgkin lymphoma;
- Discuss the appropriate sequencing of agents in chronic lymphocytic leukemia (CLL) treatment based upon the latest scientific evidence;
- Identify patients in need of central nervous system (CNS) lymphoma prophylaxis using the latest guidelines;
- Distinguish when to employ treatments for various T-cell lymphoma histologies;
- Outline how timing affects the use of CAR-T as a therapeutic option for lymphoma.
RESERVATIONS AND RATES
Check-in: 3:00pm, Check-out: 12:00pm
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-834-3730 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Associate Professor of Medicine
Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
Professor of Medicine
Division of Hematology/Oncology
Feinberg School of Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Early Bird Code
|Profession Type||Early Bird||Early Bird Code||Regular Registration|
|All Profession Types||$75|
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $150 administrative fee will be refunded when written notification is received by April 4, 2018. No refunds will be made after April 4, 2018.